Korro Bio posts Q2 2026 results, highlights KRRO-121 and new candidate KRRO-111
Korro reported $137.9 million in cash and said KRRO-121 remains set to enter the clinic in the second half of 2026 while KRRO-111 advances as a development candidate for AATD.
SEC filing